Microchip's Q3 Net Income Plunges 82% Amid Sales Decline
Ticker: MCHPP · Form: 10-Q · Filed: Nov 6, 2025 · CIK: 827054
| Field | Detail |
|---|---|
| Company | Microchip Technology Inc (MCHPP) |
| Form Type | 10-Q |
| Filed Date | Nov 6, 2025 |
| Risk Level | high |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.001, $2.75 billion, $2.25 billion |
| Sentiment | bearish |
Sentiment: bearish
Topics: Semiconductors, Earnings Decline, Cash Flow, Preferred Stock, Debt Management, Technology Licensing, Microcontrollers
Related Tickers: MCHP, MCHPP, SOXX, SMH
TL;DR
**MCHP's Q3 numbers are a red flag; net income cratered, and cash is burning – time to be cautious.**
AI Summary
Microchip Technology Inc. (MCHP) reported a significant decline in net income and revenue for the three and six months ended September 30, 2025, compared to the prior year. Net sales decreased by 2.0% to $1,140.4 million for the three months ended September 30, 2025, from $1,163.8 million in the same period of 2024. For the six-month period, net sales dropped by 7.9% to $2,215.9 million from $2,405.1 million. Net income attributable to common stockholders plummeted by 82.3% to $13.9 million for the three-month period, down from $78.4 million, and resulted in a net loss of $32.5 million for the six-month period, a stark contrast to the $207.7 million net income in the prior year. This decline was primarily driven by a $55.6 million dividend payment on Series A Preferred Stock for the six months, increased operating expenses, and a decrease in gross profit. Operating income fell by 39.4% to $88.9 million for the three months and by 66.9% to $121.0 million for the six months. The company also saw a substantial decrease in cash and cash equivalents, from $771.7 million at March 31, 2025, to $236.8 million at September 30, 2025, largely due to net cash used in financing activities totaling $799.7 million. Long-term debt decreased slightly from $5,630.4 million to $5,375.9 million.
Why It Matters
This filing reveals a challenging period for Microchip Technology, with significant declines in profitability and revenue. For investors, the sharp drop in net income and the net loss for the six-month period, exacerbated by preferred stock dividends, signal potential headwinds and could impact future dividend sustainability for common stockholders. Employees might face increased pressure as the company navigates a tougher financial landscape. Customers could see potential impacts on product roadmaps or supply chain stability if financial performance continues to deteriorate. In the broader market, Microchip's performance reflects potential softening in the semiconductor sector, impacting competitors and the overall tech industry outlook.
Risk Assessment
Risk Level: high — The risk level is high due to the substantial 82.3% decrease in net income attributable to common stockholders for the three months ended September 30, 2025, and a net loss of $32.5 million for the six-month period, compared to net income of $207.7 million in the prior year. Additionally, cash and cash equivalents decreased by $534.9 million in six months, from $771.7 million to $236.8 million, indicating significant cash outflow.
Analyst Insight
Investors should carefully re-evaluate their position in MCHP, considering the significant decline in profitability and cash reserves. Monitor upcoming earnings calls for management's strategy to address the revenue and net income slump, and assess the impact of the Series A Preferred Stock dividends on common shareholder returns.
Financial Highlights
- debt To Equity
- 0.80
- revenue
- $1,140.4M
- operating Margin
- 7.8%
- total Assets
- $14,469.7M
- total Debt
- $5,375.9M
- net Income
- $41.7M
- eps
- $0.03
- gross Margin
- 55.9%
- cash Position
- $236.8M
- revenue Growth
- -2.0%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Total Net Sales | $1,140.4M | -2.0% |
| Total Net Sales | $2,215.9M | -7.9% |
Key Numbers
- $1,140.4M — Net Sales (2.0% decrease for three months ended September 30, 2025, year-over-year)
- $13.9M — Net Income Attributable to Common Stockholders (82.3% decrease for three months ended September 30, 2025, year-over-year)
- ($32.5M) — Net Loss Attributable to Common Stockholders (For six months ended September 30, 2025, compared to $207.7M net income in prior year)
- $236.8M — Cash and Cash Equivalents (Decreased from $771.7M at March 31, 2025)
- $55.6M — Dividends on Series A Preferred Stock (Paid for six months ended September 30, 2025)
- $5,375.9M — Long-term Debt (Decreased from $5,630.4M at March 31, 2025)
- $0.03 — Basic Net Income Per Common Share (For three months ended September 30, 2025, down from $0.15)
- ($0.06) — Basic Net Loss Per Common Share (For six months ended September 30, 2025, down from $0.39 net income)
- $799.7M — Net Cash Used in Financing Activities (For six months ended September 30, 2025)
- 540,446,834 — Common Shares Outstanding (As of October 28, 2025)
Key Players & Entities
- MICROCHIP TECHNOLOGY INCORPORATED (company) — Registrant
- J.P. Morgan Chase Bank, N.A. (company) — Administrative agent for Credit Agreement
- NASDAQ Stock Market LLC (regulator) — Exchange for MCHP and MCHPP
- U.S. Securities and Exchange Commission (regulator) — Regulatory body for 10-Q filing
- Financial Accounting Standards Board (regulator) — Issued accounting standards updates
- $1,140.4 million (dollar_amount) — Net sales for three months ended September 30, 2025
- $13.9 million (dollar_amount) — Net income attributable to common stockholders for three months ended September 30, 2025
- $32.5 million (dollar_amount) — Net loss attributable to common stockholders for six months ended September 30, 2025
- $55.6 million (dollar_amount) — Dividends on Series A Preferred Stock for six months ended September 30, 2025
- $236.8 million (dollar_amount) — Cash and cash equivalents at September 30, 2025
FAQ
What were Microchip Technology's net sales for the three months ended September 30, 2025?
Microchip Technology's net sales for the three months ended September 30, 2025, were $1,140.4 million, a decrease from $1,163.8 million in the same period of 2024.
How did Microchip Technology's net income attributable to common stockholders change year-over-year for the three months ended September 30, 2025?
Net income attributable to common stockholders for the three months ended September 30, 2025, was $13.9 million, an 82.3% decrease from $78.4 million in the same period of 2024.
What was Microchip Technology's cash and cash equivalents balance at September 30, 2025?
At September 30, 2025, Microchip Technology had cash and cash equivalents of $236.8 million, a significant decrease from $771.7 million at March 31, 2025.
What impact did Series A Preferred Stock dividends have on Microchip Technology's net income?
Dividends on Series A Preferred Stock totaled $55.6 million for the six months ended September 30, 2025, contributing to a net loss attributable to common stockholders of $32.5 million for that period.
What were the key drivers behind the decrease in Microchip Technology's operating income?
Operating income decreased due to a decline in gross profit and an increase in operating expenses, including research and development, selling, general and administrative, and special charges.
How much long-term debt did Microchip Technology have at September 30, 2025?
Microchip Technology's long-term debt stood at $5,375.9 million at September 30, 2025, a reduction from $5,630.4 million at March 31, 2025.
What are the two operating segments of Microchip Technology?
Microchip Technology's business is comprised of two operating segments: semiconductor products and technology licensing, as evaluated by the Chief Operating Decision Maker.
What accounting pronouncements is Microchip Technology evaluating for future adoption?
Microchip Technology is evaluating ASU 2023-09, 'Improvements to Income Tax Disclosures,' effective for the fiscal period ending March 31, 2026, and ASU 2024-03, 'Disaggregation of Income Statement Expenses,' effective for annual periods beginning after December 15, 2026.
What was the basic net income (loss) per common share for Microchip Technology for the six months ended September 30, 2025?
For the six months ended September 30, 2025, Microchip Technology reported a basic net loss per common share of $0.06, a significant decline from a basic net income per common share of $0.39 in the prior year.
How did Microchip Technology's net cash provided by operating activities change?
Net cash provided by operating activities decreased to $363.7 million for the six months ended September 30, 2025, from $420.7 million in the same period of 2024.
Risk Factors
- Economic Downturns and Demand Fluctuations [high — market]: The company's revenue is sensitive to global economic conditions. A significant economic downturn or slowdown in the semiconductor industry could lead to reduced customer demand for Microchip's products, impacting net sales and profitability. For the three months ended September 30, 2025, net sales decreased by 2.0% year-over-year.
- Supply Chain Disruptions [medium — operational]: Microchip relies on a complex global supply chain for its manufacturing and distribution. Disruptions, such as those caused by geopolitical events, natural disasters, or pandemics, could impact the availability of raw materials and components, leading to production delays and increased costs.
- Debt Obligations and Interest Expense [medium — financial]: The company carries significant long-term debt ($5,375.9 million as of September 30, 2025). Fluctuations in interest rates or an inability to service this debt could negatively affect financial performance. Interest expense was $56.3 million for the three months ended September 30, 2025.
- Compliance with Export Controls and Trade Regulations [medium — regulatory]: As a global technology company, Microchip is subject to various export control laws and trade regulations. Non-compliance could result in significant fines, penalties, and reputational damage, impacting its ability to conduct business internationally.
- Intense Competition and Technological Obsolescence [high — operational]: The semiconductor industry is highly competitive, with rapid technological advancements. Microchip faces competition from numerous players, and failure to innovate or keep pace with technological changes could lead to a loss of market share and reduced competitiveness.
- Impact of Preferred Stock Dividends [high — financial]: The payment of dividends on Series A Preferred Stock significantly impacted net income. For the six months ended September 30, 2025, $55.6 million in dividends were paid, contributing to a net loss of $32.5 million for the period, compared to a net income of $207.7 million in the prior year.
Industry Context
Microchip Technology operates in the highly competitive and cyclical semiconductor industry, which is characterized by rapid technological advancements and significant capital investment. The industry is influenced by global economic conditions, consumer demand for electronic devices, and automotive production. Recent trends include a focus on specialized microcontrollers, analog components, and embedded solutions, areas where Microchip has a strong presence.
Regulatory Implications
Microchip Technology is subject to various U.S. and international regulations, including export controls, trade sanctions, and environmental standards. Compliance is critical to avoid penalties and maintain market access. The company's global operations necessitate careful navigation of diverse regulatory landscapes.
What Investors Should Do
- Monitor inventory levels and gross margins
- Analyze the impact of preferred stock dividends on common equity
- Assess the company's cash burn and financing activities
- Evaluate the sustainability of operating expenses
Key Dates
- 2025-09-30: End of Second Fiscal Quarter — Reporting period for the 10-Q, showing a decline in net sales and a significant drop in net income compared to the prior year.
- 2025-03-31: End of First Fiscal Quarter — Previous reporting period, showing a higher cash balance ($771.7M) and long-term debt ($5,630.4M) than at September 30, 2025.
Glossary
- Net Sales
- The total revenue generated from the sale of goods or services, net of returns, allowances, and discounts. (Indicates the company's top-line performance and market demand for its products.)
- Gross Profit
- Net sales minus the cost of goods sold. It represents the profit a company makes after deducting the costs associated with making and selling its products. (Measures the efficiency of production and pricing strategies.)
- Operating Income
- Gross profit minus operating expenses (R&D, SG&A, amortization, etc.). It reflects the profitability of the company's core business operations. (Shows how well the company is managing its day-to-day operations.)
- Net Income Attributable to Common Stockholders
- The portion of net income available to common shareholders after all expenses, taxes, interest, and preferred dividends have been paid. (Key measure of profitability for common shareholders.)
- Cash and Cash Equivalents
- Highly liquid short-term investments that are readily convertible to known amounts of cash and which are so near their maturity that they present an insignificant risk of changes in value. (Indicates the company's short-term liquidity and ability to meet immediate obligations.)
- Long-term Debt
- Financial obligations that are due more than one year from the balance sheet date. (Represents the company's leverage and long-term financing structure.)
- Series A mandatory convertible preferred stock
- A class of preferred stock that is required to convert into a fixed number of common shares by a specified date. (Its dividends and liquidation preference impact net income and equity calculations.)
- Amortization of acquired intangible assets
- The systematic allocation of the cost of an intangible asset over its useful life, typically related to assets acquired in a business combination. (A non-cash expense that reduces operating income, reflecting the consumption of value from acquired intangibles.)
Year-Over-Year Comparison
Compared to the prior year's comparable periods, Microchip Technology Inc. has experienced a notable downturn. Net sales for the three months ended September 30, 2025, decreased by 2.0% to $1,140.4 million, and for the six-month period, they fell by 7.9% to $2,215.9 million. The most striking change is in net income, which plummeted by 82.3% to $13.9 million for the quarter and resulted in a net loss of $32.5 million for the six months, a stark contrast to the $207.7 million net income in the prior year. This decline is exacerbated by increased operating expenses and the impact of preferred stock dividends.
Filing Stats: 4,760 words · 19 min read · ~16 pages · Grade level 7.4 · Accepted 2025-11-06 16:27:11
Key Financial Figures
- $0.001 — ange on Which Registered Common Stock, $0.001 par value per share MCHP NASDAQ Stock M
- $2.75 billion — rm unsecured promissory notes, of up to $2.75 billion outstanding at any one time, further up
- $2.25 billion — ing at any one time, further updated to $2.25 billion outstanding at any one time pursuant to
Filing Documents
- mchp-20250930.htm (10-Q) — 1800KB
- ex311q2fy26.htm (EX-31.1) — 10KB
- ex312q2fy26.htm (EX-31.2) — 10KB
- ex32q2fy26.htm (EX-32) — 8KB
- mchp-20250930_g1.jpg (GRAPHIC) — 32KB
- 0000827054-25-000183.txt ( ) — 8643KB
- mchp-20250930.xsd (EX-101.SCH) — 39KB
- mchp-20250930_cal.xml (EX-101.CAL) — 83KB
- mchp-20250930_def.xml (EX-101.DEF) — 253KB
- mchp-20250930_lab.xml (EX-101.LAB) — 609KB
- mchp-20250930_pre.xml (EX-101.PRE) — 451KB
- mchp-20250930_htm.xml (XML) — 1436KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION Item 1.
Financial Statements (Unaudited)
Financial Statements (Unaudited) Condensed Consolidated Balance Sheets – September 30, 2025 and March 31, 202 5 4 Condensed Consolidated Statements of Operations – Three and Six Months Ended September 30, 2025 and 202 4 5 Condensed Consolidated Statements of Comprehensive Income – Three and Six Months Ended September 30, 2025 and 202 4 6 Condensed Consolidated Statements of Cash Flows – Six Months Ended September 30, 2025 and 202 4 7 Condensed Consolidated Statements of Changes in Equity - Three and Six Months Ended September 30, 2025 and 2024 8 Notes to Condensed Consolidated Financial Statements 10 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 38 Item 4.
Controls and Procedures
Controls and Procedures 39
OTHER INFORMATION
PART II. OTHER INFORMATION Item 1.
Legal Proceedings
Legal Proceedings 40 Item 1A.
Risk Factors
Risk Factors 40 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 67 Item 3. Defaults Upon Senior Securities 67 Item 4. Mine Safety Disclosures 67 Item 5. Other Information 67 Item 6. Exhibits 68
Signatures
Signatures 2 MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES Defined Terms (1) Term Definition 4.250% 2025 Notes 2025 Senior Unsecured Notes, matured on September 1, 2025 4.900% 2028 Notes 2028 Senior Unsecured Notes, maturing on March 15, 2028 5.050% 2029 Notes 2029 Senior Unsecured Notes, maturing on March 15, 2029 5.050% 2030 Notes 2030 Senior Unsecured Notes, maturing on February 15, 2030 2015 Senior Convertible Debt 2015 Senior Convertible Debt, matured on February 15, 2025 2017 Senior Convertible Debt 2017 Senior Convertible Debt, maturing on February 15, 2027 2020 Senior Convertible Debt 2020 Senior Convertible Debt, matured on November 15, 2024 2024 Senior Convertible Debt 2024 Senior Convertible Debt, maturing on June 1, 2030 ASU Accounting Standards Update CEMs Client engagement managers CHIPS Act CHIPS and Science Act of 2022 Commercial Paper Short-term unsecured promissory notes, of up to $2.75 billion outstanding at any one time, further updated to $2.25 billion outstanding at any one time pursuant to the Credit Agreement, as amended in March 2025 Convertible Debt 2015 Senior Convertible Debt, 2017 Senior Convertible Debt, 2020 Senior Convertible Debt and 2024 Senior Convertible Debt. Credit Agreement Amended and Restated Credit Agreement, dated as of December 16, 2021, among the Company, as borrower, the lenders from time to time party thereto, and J.P. Morgan Chase Bank, N.A., as administrative agent, as amended by the Second Amended and Restated Credit Agreement, dated as of March 25, 2025 Depositary Shares Depositary Shares, each representing a 1/20th interest in a share of Series A Preferred Stock EAR Export Administration Regulation ESG Environmental, social and governance Exchange Act Securities Exchange Act of 1934, as amended FAEs Field applications engineers FASB Financial Accounting Standards Board FPGA Field-programmable gate array LTSAs Long-term supply agreements OEMs Original equipment manufacturers
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
. Financial Statements
Item 1 . Financial Statements MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (in millions, except share and per share amounts; unaudited) ASSETS September 30, March 31, 2025 2025 Cash and cash equivalents $ 236.8 $ 771.7 Accounts receivable, net 746.2 689.7 Inventories 1,095.3 1,293.5 Other current assets 272.0 236.4 Total current assets 2,350.3 2,991.3 Property, plant and equipment, net 1,153.5 1,183.7 Goodwill 6,695.5 6,684.8 Intangible assets, net 2,169.5 2,389.0 Long-term deferred tax assets 1,739.0 1,728.1 Other assets 361.9 397.7 Total assets $ 14,469.7 $ 15,374.6 LIABILITIES AND STOCKHOLDERS' EQUITY Accounts payable $ 170.0 $ 160.6 Accrued liabilities 873.8 994.5 Total current liabilities 1,043.8 1,155.1 Long-term debt 5,375.9 5,630.4 Long-term income tax payable 561.1 633.4 Long-term deferred tax liability 35.2 33.8 Other long-term liabilities 758.2 843.6 Stockholders' equity: Preferred stock, $ 0.001 par value per share; authorized 5,000,000 shares; 7.50% Series A mandatory convertible preferred stock, 1,485,000 shares issued and outstanding at September 30, 2025 and March 31, 2025, with a liquidation preference of $ 1,000 per share, or $ 1,485.0 million in the aggregate — — Common stock, $ 0.001 par value per share; authorized 900,000,000 shares; 578,423,869 shares issued and 540,446,319 shares outstanding at September 30, 2025; 577,996,915 shares issued and 538,704,604 shares outstanding at March 31, 2025 0.6 0.6 Additional paid-in capital 4,028.5 3,909.9 Common stock held in treasury: 37,977,550 shares at September 30, 2025; 39,292,311 shares at March 31, 2025 ( 2,584.7 ) ( 2,611.6 ) Accumulated other comprehensive loss ( 6.2 ) ( 1.7 ) Retained earnings 5,257.3 5,781.1 Total stockholders' equity 6,695.5 7,078.3 Total liabilities and stockholders' equity $ 14,469.7 $ 15,374.6 See accompanying notes to condensed consolidated financial statements 4 Table of Contents M